IMPACT THERAPEUTICS, INC - B - H SHARES
(HKEX: 7630)
IMPACT Therapeutics, Inc. engages in the manufacture of pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China.
40.040 -
+0.040
(+0.10%)
Range
38.980 - 47.980
(23.09%)
Open
38.980
Previous Close
40.000
Bid Price
39.540
Bid Volume
('000)
3.4
Ask Price
40.040
Ask Volume
('000)
1
Volume
('000)
1,693.5
Value
71,766,818
Remark
-
Delayed prices. Updated at 16 May 2026 00:09.
Data powered by
View All Events
Please login to view stock data and analysis
